Ji‐Li Chen

3.5k total citations · 1 hit paper
23 papers, 2.6k citations indexed

About

Ji‐Li Chen is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ji‐Li Chen has authored 23 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 10 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ji‐Li Chen's work include Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (11 papers). Ji‐Li Chen is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (11 papers). Ji‐Li Chen collaborates with scholars based in United Kingdom, Germany and China. Ji‐Li Chen's co-authors include Vincenzo Cerundolo, P. Rod Dunbar, Graham S. Ogg, Pedro Romero, Mariolina Salio, Jean‐Charles Cerottini, Danielle Líénard, Danila Valmori, Mikäel J. Pittet and Donata Rimoldi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Ji‐Li Chen

22 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells

2010 531 citations Mariolina Salio, Ji‐Li Chen et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji‐Li Chen United Kingdom	19	2.2k	719	624	250	176	23	2.6k
Jeffrey C. Nolz United States	23	1.5k 0.7×	430 0.6×	397 0.6×	219 0.9×	142 0.8×	35	2.0k
José A. Guevara-Patiño United States	24	1.7k 0.8×	809 1.1×	522 0.8×	319 1.3×	148 0.8×	54	2.2k
Marc‐André Wurbel United States	18	1.9k 0.9×	540 0.8×	567 0.9×	139 0.6×	109 0.6×	22	2.4k
Pieter Spee Denmark	20	1.4k 0.7×	424 0.6×	557 0.9×	166 0.7×	183 1.0×	32	1.9k
Vincenzo Di Bartolo France	28	1.4k 0.6×	470 0.7×	722 1.2×	180 0.7×	213 1.2×	52	2.2k
Joyce C. Solheim United States	30	1.6k 0.7×	714 1.0×	1.1k 1.7×	300 1.2×	207 1.2×	94	2.7k
Danita H. Schuurhuis Netherlands	26	1.9k 0.9×	928 1.3×	888 1.4×	79 0.3×	231 1.3×	36	2.8k
Petra Keikavoussi Germany	15	2.4k 1.1×	1.2k 1.7×	1.3k 2.1×	75 0.3×	201 1.1×	18	2.9k
Jane Oliaro Australia	25	1.8k 0.8×	786 1.1×	1.0k 1.6×	206 0.8×	249 1.4×	49	2.8k
Leremy A. Colf United States	13	651 0.3×	254 0.4×	571 0.9×	359 1.4×	225 1.3×	16	1.5k

Countries citing papers authored by Ji‐Li Chen

Since Specialization

Citations

This map shows the geographic impact of Ji‐Li Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Li Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Li Chen more than expected).

Fields of papers citing papers by Ji‐Li Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Li Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Li Chen. The network helps show where Ji‐Li Chen may publish in the future.

Co-authorship network of co-authors of Ji‐Li Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Li Chen. A scholar is included among the top collaborators of Ji‐Li Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Li Chen. Ji‐Li Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Hongfei, Zhennan Zhao, Ping Fei, et al.. (2024). Characterization of N6-methyladenosine long non-coding RNAs in sporadic congenital cataract and age-related cataract. International Journal of Ophthalmology. 17(11). 1973–1986.

Woodcock, Victoria K., Ji‐Li Chen, Karin Purshouse, et al.. (2023). PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer. SHILAP Revista de lepidopterología. 4(3). 322–330. 6 indexed citations

Dölen, Yusuf, Uzi Gileadi, Ji‐Li Chen, et al.. (2021). PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses. Frontiers in Immunology. 12. 641703–641703. 30 indexed citations

Prota, Gennaro, Uzi Gileadi, Margarida Rei, et al.. (2020). Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells. Cancer Immunology Research. 8(5). 685–697. 10 indexed citations

Corridoni, Daniele, Seiji Shiraishi, Thomas Chapman, et al.. (2019). NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses. Frontiers in Immunology. 10. 958–958. 19 indexed citations

Hamid, Megat Abd, Huw Colin‐York, Nasullah Khalid Alham, et al.. (2019). Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses. Cancer Immunology Research. 8(2). 203–216. 27 indexed citations

Chen, Ji‐Li, Andrea Tarlton, Sacha Gnjatic, et al.. (2014). NY‐ESO ‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO ‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO ‐1 fowlpox virus. International Journal of Cancer. 136(6). E590–601. 40 indexed citations

Chen, Ji‐Li, Dawn Shepherd, Andrea Tarlton, et al.. (2014). High Frequency of Cytolytic 21-Hydroxylase–Specific CD8+ T Cells in Autoimmune Addison’s Disease Patients. The Journal of Immunology. 193(5). 2118–2126. 32 indexed citations

Chen, Ji‐Li, Anthony J. Morgan, Guillaume Stewart-Jones, et al.. (2010). Ca2+ Release from the Endoplasmic Reticulum of NY-ESO-1–Specific T Cells Is Modulated by the Affinity of TCR and by the Use of the CD8 Coreceptor. The Journal of Immunology. 184(4). 1829–1839. 31 indexed citations

10.

Purbhoo, Marco A., Deborah H. Sutton, Joanna E. Brewer, et al.. (2006). Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors. The Journal of Immunology. 176(12). 7308–7316. 74 indexed citations

11.

Chen, Ji‐Li, Guillaume Stewart-Jones, Giovanna Bossi, et al.. (2005). Structural and kinetic basis for heightened immunogenicity of T cell vaccines. The Journal of Experimental Medicine. 201(8). 1243–1255. 215 indexed citations

12.

Choi, E, Ji‐Li Chen, Linda Wooldridge, et al.. (2003). High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining. The Journal of Immunology. 171(10). 5116–5123. 75 indexed citations

13.

Palmowski, Michael J., E Choi, Ian F. Hermans, et al.. (2002). Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols. The Journal of Immunology. 168(9). 4391–4398. 135 indexed citations

14.

Karadimitris, Anastasios, Stephan D. Gadola, Myriam M. Altamirano, et al.. (2001). Human CD1d–glycolipid tetramers generated byin vitrooxidative refolding chromatography. Proceedings of the National Academy of Sciences. 98(6). 3294–3298. 156 indexed citations

15.

Chen, Ji‐Li, P. Rod Dunbar, Uzi Gileadi, et al.. (2000). Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL. The Journal of Immunology. 165(2). 948–955. 145 indexed citations

16.

Dunbar, P. Rod, Ji‐Li Chen, David Chao, et al.. (1999). Cutting Edge: Rapid Cloning of Tumor-Specific CTL Suitable for Adoptive Immunotherapy of Melanoma. The Journal of Immunology. 162(12). 6959–6962. 79 indexed citations

17.

Ogg, Graham S., P. Rod Dunbar, Pedro Romero, Ji‐Li Chen, & Vincenzo Cerundolo. (1998). High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo. The Journal of Experimental Medicine. 188(6). 1203–1208. 363 indexed citations

18.

Romero, Pedro, P. Rod Dunbar, Danila Valmori, et al.. (1998). Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes. The Journal of Experimental Medicine. 188(9). 1641–1650. 434 indexed citations

19.

Li, Ji‐Liang, Kathryn Robson, Ji‐Li Chen, Geoffrey Targett, & David A. Baker. (1996). Pfmrk, A MO15‐Related Protein Kinase from Plasmodium falciparum. European Journal of Biochemistry. 241(3). 805–813. 58 indexed citations

20.

Chen, Ji‐Li, et al.. (1991). Immunization strategies for the production of rat monoclonal anti-idiotope antibodies. Journal of Immunological Methods. 142(1). 15–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact